Home - Invivoscribe

Cat #: 23100071

BCR/ABL t(9;22) Mix 3b – 6FAM for ABI Fluorescence Detection

BCR/ABL translocations are associated with a variety of hematologic malignancies. The Philadelphia chromosome (Ph1) is a specific chromosomal abnorm...

View Product

Cat #: 23100081

BCR/ABL t(9;22) Mix 3c – 6FAM for ABI Fluorescence Detection

BCR/ABL translocations are associated with a variety of hematologic malignancies. The Philadelphia chromosome (Ph1) is a specific chromosomal abnorm...

View Product

Cat #: 23100101

BCR/ABL t(9;22) Mix 3d – 6FAM for ABI Fluorescence Detection

BCR/ABL translocations are associated with a variety of hematologic malignancies. The Philadelphia chromosome (Ph1) is a specific chromosomal abnorm...

View Product

Cat #: 13100031

BCR/ABL t(9;22) Translocation Assay for ABI Fluorescence Detection

BACKGROUND BCR/ABL translocations are associated with a variety of hematologic malignancies. The Philadelphia chromosome (Ph1) is a specific chromos...

View Product

Cat #: 13100010

BCR/ABL t(9;22) Translocation Assay for Gel Detection

BACKGROUND BCR/ABL translocations are associated with a variety of hematologic malignancies. The Philadelphia chromosome (Ph1) is a specific chromos...

View Product

Cat #: 24120031

FLT3 D835 Master Mix – 6FAM for ABI Fluorescence Detection

FLT3 is a receptor tyrosine kinase that is normally expressed on many cell types including hematologic stem cells. Mutation of the FLT3 receptor, by...

View Product

Cat #: 24120011

FLT3 ITD Master Mix – 6FAM & HEX for ABI Fluorescence Detection

FLT3 is a receptor tyrosine kinase that is normally expressed on many cell types including hematologic stem cells. Mutation of the FLT3 receptor, by...

View Product

Cat #: 14120031

FLT3 Mutation Assay – ABI Fluorescence Detection

BACKGROUND FLT3 is a receptor tyrosine kinase that is normally expressed on many cell types including hematologic stem cells. Mutation of the FLT3 r...

View Product

Cat #: 14120010

FLT3 Mutation Assay – Gel Detection

BACKGROUND FLT3 is a receptor tyrosine kinase that is normally expressed on many cell types including hematologic stem cells. Mutation of the FLT3 r...

View Product

Cat #: 14120020

FLT3 Mutation Assay MegaKit – Gel Detection

BACKGROUND FLT3 is a receptor tyrosine kinase that is normally expressed on many cell types including hematologic stem cells. Mutation of the FLT3 r...

View Product

Cat #: 11000031

IGH + IGK B-Cell Clonality Assay – ABI Fluorescence Detection

BACKGROUND Rearrangements of the antigen receptor genes occur during ontogeny in B and T lymphocytes. These gene rearrangements generate products th...

View Product

Cat #: 11000010

IGH + IGK B-Cell Clonality Assay for Gel Detection

BACKGROUND Rearrangements of the antigen receptor genes occur during ontogeny in B and T lymphocytes. These gene rearrangements generate products th...

View Product

Cat #: 11000041

IGH + IGK B-Cell Clonality Assay MegaKit – ABI Fluorescence Detection

BACKGROUND Rearrangements of the antigen receptor genes occur during ontogeny in B and T lymphocytes. These gene rearrangements generate products th...

View Product

Cat #: IGH Clonality

IGH Clonality Assays

Lymphoid cells are different from the other somatic cells in the body as during development, the antigen receptor genes of these cells undergo somatic...

View Product

Cat #: A1010041

IGH DH1-6 – HEX

This product targets the diversity and joining regions of the human immunoglobulin heavy chain gene. ...

View Product

Cat #: A1010051

IGH DH7 – 6FAM

This product targets the diversity and joining regions of the human immunoglobulin heavy chain gene. ...

View Product

Cat #: A1010011

IGH FR1- 6FAM

This product targets the framework 1 region of the human immunoglobulin heavy chain gene. ...

View Product

Cat #: A1010101

IGH FR2 – 6FAM

This product targets the framework 2 region of the human immunoglobulin heavy chain gene. ...

View Product

Cat #: A1010020

IGH FR2 – Unlabeled

This product targets the framework 2 region of the human immunoglobulin heavy chain gene. ...

View Product

Cat #: A1010031

IGH FR3 – HEX

This product targets the framework 3 region of the human immunoglobulin heavy chain gene. ...

View Product

Invivoscribe provides a full range of standardized CE-marked in vitro diagnostic cGMP products for hematology-oncology, as well as RUO assays, analyte specific reagents (ASRs), and DNA & RNA controls.

The Laboratory for Personalized Molecular Medicine^® (LabPMM^®) at Invivoscribe offer internationally standardized testing of novel and proprietary biomarkers that are critically important for patient care.

Browse our comprehensive menu of product & testing services.

A proven strategy to accelerate drug approvals

Design Controls, Bioinformatics Software, Identify & Track, Custom Development, and Complementary MRD Assays

cGMP Compliant, CE-marked IVDs & CDx Manufacturing, Assay Development, and Controls & Reagents

Clinical Lab Experience, Internationally Standardized, Comprehensive Panels, Complementary MRD Assays, and Worldwide Enrollment

Accredited & Proven, Registered Medical Device Establishment, Multiple CDx Approvals, CE-marked IVDs, and Marketing Authorization Holder (MAH)

We take pride in expanding the science that bridges personalized medicine with quality healthcare.

Personalized Molecular Medicine^® is use of genomics and patient specific information to identify optimal treatment for each patient.

November 17th, 2020
Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing

April 20th, 2021
Validation of a Next-Generation Sequencing-based T-Cell Receptor Gamma Gene Rearrangement Diagnostic Assay: Transitioning from Capillary Electrophoresis to Next-Generation Sequencing

November 17th, 2020
Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing

PRODUCTS & CLINICAL LAB SERVICES

Now Available

Our New Document Search Feature

Need Help Placing an Online Order?

Contact our Customer Service Team

Now Available

Our New Document Search Feature

Need Help Placing an Online Order?

Contact our Customer Service Team

Invivoscribe provides a full range of standardized CE-marked in vitro diagnostic cGMP products for hematology-oncology, as well as RUO assays, analyte specific reagents (ASRs), and DNA & RNA controls.

The Laboratory for Personalized Molecular Medicine® (LabPMM®) at Invivoscribe offer internationally standardized testing of novel and proprietary biomarkers that are critically important for patient care.

Browse our comprehensive menu of product & testing services.

A proven strategy to accelerate drug approvals

Design Controls, Bioinformatics Software, Identify & Track, Custom Development, and Complementary MRD Assays

cGMP Compliant, CE-marked IVDs & CDx Manufacturing, Assay Development, and Controls & Reagents

Clinical Lab Experience, Internationally Standardized, Comprehensive Panels, Complementary MRD Assays, and Worldwide Enrollment

Accredited & Proven, Registered Medical Device Establishment, Multiple CDx Approvals, CE-marked IVDs, and Marketing Authorization Holder (MAH)

We take pride in expanding the science that bridges personalized medicine with quality healthcare.

Personalized Molecular Medicine® is use of genomics and patient specific information to identify optimal treatment for each patient.

November 17th, 2020 Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing

April 20th, 2021 Validation of a Next-Generation Sequencing-based T-Cell Receptor Gamma Gene Rearrangement Diagnostic Assay: Transitioning from Capillary Electrophoresis to Next-Generation Sequencing

November 17th, 2020 Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing

PRODUCTS & CLINICAL LAB SERVICES

Now Available

Our New Document Search Feature

Need Help Placing an Online Order?

Contact our Customer Service Team

Now Available

Our New Document Search Feature

Need Help Placing an Online Order?

Contact our Customer Service Team

The Laboratory for Personalized Molecular Medicine^® (LabPMM^®) at Invivoscribe offer internationally standardized testing of novel and proprietary biomarkers that are critically important for patient care.

Personalized Molecular Medicine^® is use of genomics and patient specific information to identify optimal treatment for each patient.

November 17th, 2020
Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing

April 20th, 2021
Validation of a Next-Generation Sequencing-based T-Cell Receptor Gamma Gene Rearrangement Diagnostic Assay: Transitioning from Capillary Electrophoresis to Next-Generation Sequencing

November 17th, 2020
Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing